本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vaxcyte, Inc.

36.63
+0.39001.08%
盘后36.630.00000.00%16:40 EDT
成交量:108.87万
成交额:3,950.34万
市值:47.25亿
市盈率:-9.20
高:37.00
开:36.14
低:35.46
收:36.24
数据加载中...
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities